BiolineRX will conduct a Phase II trial of a combination of Merck’s KEYTRUDA and its BL-8040 in treating pancreatic cancer.
12/01/2016, 16:07
BiolineRx, Merck agree cancer drugs collaboration
Supporting Israel, Educating New Hampshire
Follow us on: 
